CAS: 1628256-23-4
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
Lerociclib (G1T38) REF: 3D-DQC25623CAS: 1628256-23-4 | Min. 95% | 355.00 €~2,173.00 € | Mon 17 Mar 25 | |
Lerociclib REF: TM-T11345CAS: 1628256-23-4 | 98% | 68.00 €~764.00 € | Mon 07 Apr 25 |
Lerociclib (G1T38)
CAS:1628256-23-4
Lerociclib (G1T38) is a potent inhibitor of breast cancer cells with structural similarity to palbociclib. …
Formula:
C26H34N8O
Purity:
Min. 95%
Molecular weight:
474.61 g/mol
Ref: 3D-DQC25623
5mg | 355.00 € | ||
10mg | 505.00 € | ||
25mg | 902.00 € | ||
50mg | 1,359.00 € | ||
100mg | 2,173.00 € |
Estimated delivery in United States, on Monday 17 Mar 2025
Lerociclib
CAS:1628256-23-4
Lerociclib (G1T38) is a CDK4/6 inhibitor with anticancer and antitumor activities, inhibiting CDK4/CyclinD1 and CDK6/CyclinD3.
Formula:
C26H34N8O
Purity:
98%
Color and Shape:
Solid
Molecular weight:
474.6
Ref: TM-T11345
1mg | 68.00 € | ||
5mg | 153.00 € | ||
10mg | 217.00 € | ||
25mg | 362.00 € | ||
50mg | 535.00 € | ||
100mg | 764.00 € |
Estimated delivery in United States, on Monday 7 Apr 2025